Inici › Diabetis tipus 2 › Ohio › Cincinnati
Assaigs clínics de Diabetis tipus 2 a Cincinnati, OH
12 estudis de Diabetis tipus 2 busquen participants en centres de Cincinnati i voltants (en un radi d'uns 30 milles). Obre un estudi per veure qui hi pot participar i com contactar amb l'equip.
Text oficial de l'estudi (anglès)
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
ReclutantFase 2
- Velocity Clinical Research, Cincinnati, Springdale, Cincinnati
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
ReclutantFase 3
- The Christ Hospital, Cincinnati
- Velocity Clinical Research-Cincinnati-69044, Cincinnati
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
ReclutantVoluntaris sans benvinguts
- St Elizabeth Health Care - CRI, Edgewood · a 8 mi
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
ReclutantFase 3
- Midwest Eye Center, Cincinnati
- Velocity Clinical Research, Mt. Auburn, Cincinnati
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
ReclutantFase 3
- AURORA-2 Clinical Site, Cincinnati
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
ReclutantFase 2
- Velocity Clinical Research, Cincinnati, Mt. Auburn, Cincinnati
- Velocity Clinical Research - Cincinnati, Blue Ash, Cincinnati
- St. Elizabeth Healthcare, Edgewood · a 8 mi
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
ReclutantFase 3
- Velocity Clinical Research - Cincinnati, Cincinnati
- Velocity Clinical Research - Springdale, Cincinnati
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
ReclutantFase 3
- Research Site, Cincinnati
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
ReclutantFase 3
- Univ of Cincinnati Med Cent, Cincinnati
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
ReclutantFase 3
- Childrens Hospital Medical Center, Cincinnati
DISCOVERY of Risk Factors for Type 2 Diabetes in Youth
ReclutantEstudi observacional
- Cincinnati Children's Hospital, Cincinnati
Liraglutide Treatment in Patients With Maturity-onset Diabetes of the Young (MODY)
ReclutantFase 2
- Cincinnati Children's Hospital Medical Center, Cincinnati
Assaigs de Diabetis tipus 2 en altres ciutats
- San Antonio, TX37 estudis
- Houston, TX31 estudis
- Orlando, FL24 estudis
- Boston, MA20 estudis
- Miami, FL19 estudis
- Chicago, IL19 estudis
- Dallas, TX19 estudis
- Columbus, OH18 estudis
- Las Vegas, NV18 estudis
- Atlanta, GA17 estudis
- San Diego, CA17 estudis
- Los Angeles, CA16 estudis
Altres estudis a Cincinnati
- Càncer de pulmó de cèl·lules no petites35 estudis
- Càncer (tots els tipus)27 estudis
- Càncer de mama25 estudis
- Insuficiència cardíaca24 estudis
- Càncer colorrectal21 estudis
- Leucèmia mieloide aguda20 estudis
- Càncer metastàtic20 estudis
- Càncer d'ovari19 estudis
- Càncer de pulmó19 estudis
- Obesitat19 estudis
- Càncer de pròstata18 estudis
- Mieloma múltiple17 estudis
De ClinicalTrials.gov, dades recuperades el 4 d’oct. 2026. Cada estudi estableix els seus propis criteris d'elegibilitat; l'equip de l'estudi decideix qui hi pot participar.